A detailed history of Wellington Management Group LLP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 114,640 shares of COLL stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,640
Previous 97,856 17.15%
Holding current value
$3.4 Million
Previous $3.15 Million 40.6%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.4 - $39.07 $527,017 - $655,750
16,784 Added 17.15%
114,640 $4.43 Million
Q2 2024

Aug 13, 2024

BUY
$31.36 - $39.99 $241,911 - $308,482
7,714 Added 8.56%
97,856 $3.15 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $40.91 $2.82 Million - $3.69 Million
90,142 New
90,142 $3.5 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.